Helping Create Special Education Policies to Benefit Students and Teachers
Researchers at Boston University’s Wheelock Educational Policy Center are studying ways to improve teacher retention and help more kids access special education.
BU Wheelock Professor Reflects on Serving as Commissioner of the National Center for Special Education Research
Nathan Jones on what he learned from leading a federal agency during a period of change and why researchers—and universities—need to become better public storytellers.
BU Research Program Opens Doors for Boston High School Teachers, Students
Hosted by the University’s Photonics Center, the Research Experiences for Teachers (RET) program is a six-week summer research opportunity for high school and community college teachers.
Boston University Announces New Convergent Research Programs
New funding opportunities and a cluster hiring push are the first projects to emerge from Task Force on Convergent Research and Education’s recommendations.
BU-Led Framingham Heart Study Brain Aging Program Receives $31.5 Million Funding Renewal
National Institute on Aging’s five-year grant will help researchers advance understanding of Alzheimer’s and related dementias.
NSF Awards Boston University $20 Million to Help Create National “Cloud Lab” Network
Automated, AI-driven labs can remotely run experiments for researchers across the country.
What Motivates Black Women Voters?
In a new study, Boston University political scientist Christine Slaughter explores how Black women viewed Kamala Harris’ 2024 presidential campaign.
US Sunscreens Just Got More Effective. BU Dermatologist Explains Why
Michael Kwa calls approval of new ingredient, bemotrizinol, exciting for safety.
BU Leaders Ask Federal Government to Reconsider Changes to Research Grants’ Approval Process Rules
University’s letter says changes “would limit scientific discovery by injecting uncertainty”.
Boston University-Based Biopharmaceutical Accelerator Boosts New Drugs’ Chances of Success, Study Finds
CARB-X-backed novel therapeutics to combat antimicrobial resistance are nearly five times more likely to reach clinical development.